FIELD: veterinary science. SUBSTANCE: aqueous pharmaceutical solutions for injection administration to recipients have danofloxacin or its pharmaceutically acceptable salts and magnesium or zinc compound, high-molecular cosolvent and an antioxidant optionally. The solution has zinc oxide or acetate as zinc compound and magnesium oxide or chloride as magnesium compound. Method of treatment of bacterial infection involves the subcutaneous administration of indicated pharmaceutical solution to recipient that provides the improved tolerance in injection sites. EFFECT: enhanced effectiveness of the preparation. 12 cl, 21 ex
Title |
Year |
Author |
Number |
NOVEL DEPOT-PREPARATIONS FOR INJECTION |
2003 |
- Shakh Dzhejmin Chandrakant
|
RU2310450C2 |
METHOD OF PRODUCING TERRAMYCIN SOLUTION FOR INJECTIONS |
0 |
- Vilyam Vellesli Armstrong
|
SU1186074A3 |
SEPARATION OF OPTICAL ISOMERS OF 2-(DIPHENYLMETHYL)-3-(2-METHOXY-5- ISOPROPYLPHENYL)METHIAMINO-1-AZABICYCLO-[2,2,2]-OCTANE |
1996 |
- Derek L.Tikner
- Morgan Melts
|
RU2136681C1 |
3-CARBOXALDEHYDE DERIVATIVES OF QUINOLINE |
1995 |
|
RU2097379C1 |
METHOD OF PRODUCING OXITETRACYCLINE THERAPEUTIC COMPOSITION |
0 |
- Vilyam Vallesli Armstrong
- Sorabkhkumar Dzhayavantraj Desaj
|
SU1309901A3 |
2,7-SUBSTITUTED DERIVATIVES OF OCTAHYDRO-1H-[1,2-A]-PYRAZINE, PHARMACEUTICAL COMPOSITION, METHOD OF INHIBITION OF BINDING DOPAMINE WITH DOPAMINE D RECEPTOR |
1995 |
- Kishor A. Desaj
- Ehnton F. Dzh. Fliri
- Mark A. Sehnner
|
RU2163239C2 |
CRYSTALLINE FORM OF TROVAFLOXACINE ZWITTERION AND METHOD OF ITS PREPARING |
1996 |
- Duglas Dzhon Meldrem Allen
- Dehvid Bruning Dzhozef
- Timoti Norris
|
RU2144921C1 |
2,7-SUBSTITUTED DERIVATIVES OF OCTAHYDROPYRROLO[1,2-A]PYRAZINE, METHOD OF TREATMENT, PHARMACEUTICAL COMPOSITION, AND INTERMEDIATES |
1996 |
|
RU2162470C2 |
4-HETEROCYCLYL-SUBSTITUTED DERIVATIVE OF QUINAZOLINE, PHARMACEUTICAL COMPOSITION |
1995 |
|
RU2137762C1 |
DEPO-PREPARATIONS OF ACTIVE ARYLHETEROCYCLIC SUBSTANCES IN SLURRY FORM |
2003 |
- Shakh Dzhejmin Chandrakant
|
RU2292207C2 |